Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors

Abstract Background Treatment for patients with malignant peripheral nerve sheath tumors (MPNST) is an unmet clinical need. Loss of NF1 in MPNST leads to hyperactivation of RAS, however little is known about relevant downstream oncogenic signaling through RAF paralogs and effective targeted therapie...

全面介紹

書目詳細資料

Principais autores:	Jiawan Wang, Arnab Sarkar, Natalia Garcia, Lindy Zhang, Ana Calizo, Alla Lisok, Katia Campos, Funan He, Nishanth Punjaala, Teresa Marple, Kai Pollard, Siyuan Zheng, Calixto-Hope G. Lucas, Vesselina G. Cooke, Christine A. Pratilas, Angelina V. Vaseva
格式:	Artigo
語言:	Inglês
出版:	BMC 2025-09-01
叢編:	Molecular Medicine
主題:	Neurofibromatosis type 1 Malignant peripheral nerve sheath tumor RAS RAF MEK
在線閱讀:	https://doi.org/10.1186/s10020-025-01353-9
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!